Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhancing bacteriophage therapeutics through in situ production and release of heterologous antimicrobial effectors
Jiemin Du, Susanne Meile, Jasmin Baggenstos, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Engineered reporter phages for detection of Escherichia coli, Enterococcus, and Klebsiella in urine
Susanne Meile, Jiemin Du, Samuel Staubli, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
L-form conversion in Gram-positive bacteria enables escape from phage infection
Jan C. Wohlfarth, Miki Feldmüller, Alissa Schneller, et al.
Nature Microbiology (2023)
Open Access | Times Cited: 28
The untapped potential of phage model systems as therapeutic agents
Jordan Romeyer Dherbey, Frederic Bertels
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Applications of bacteriophages in precision engineering of the human gut microbiome
Xiaoxian Kuang, Juntao Shen, Linggang Zheng, et al.
Engineering Microbiology (2025) Vol. 5, Iss. 1, pp. 100189-100189
Open Access
Analysis of engineered T7 bacteriophages containing genetic sequences encoding antimicrobial peptides
Tobias Ludwig, Daniela Volke, Andor Krizsan
Frontiers in Antibiotics (2025) Vol. 3
Open Access
Examining Alternative Approaches to Antibiotic Utilisation: A Critical Evaluation of Phage Therapy and Antimicrobial Peptides Combination as Potential Alternatives
Chibuzo V. Alisigwe, Chibuzor Stanley Ikpa, Uchenna Joseph Otuonye
The Microbe (2025), pp. 100254-100254
Open Access
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics
Serena Porcari, William G. Fusco, Igor Spivak, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 5, pp. 460-475
Closed Access | Times Cited: 5
Phage lysins for intestinal microbiome modulation: current challenges and enabling techniques
Iris Pottie, Roberto Vázquez, Tom Van de Wiele, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
The global burden of antimicrobial resistance – urinary tract infections
Sibylle von Vietinghoff, Olga Shevchuk, Ulrich Dobrindt, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 4, pp. 581-588
Closed Access | Times Cited: 13
Phage Therapy for Respiratory Infections: Opportunities and Challenges
Arya Khosravi, Qingquan Chen, Arne Echterhof, et al.
Lung (2024) Vol. 202, Iss. 3, pp. 223-232
Closed Access | Times Cited: 4
Discovery and characterisation of new phage targeting uropathogenic Escherichia coli
Shahla Asgharzadeh Kangachar, Dominic Y. Logel, Ellina Trofimova, et al.
Virology (2024) Vol. 597, pp. 110148-110148
Open Access | Times Cited: 3
Bacteriophage Bioengineering: A Transformative Approach for Targeted Drug Discovery and Beyond
Longzhu Cui, Srivani Veeranarayanan, Kanate Thitiananpakorn, et al.
Pathogens (2023) Vol. 12, Iss. 9, pp. 1179-1179
Open Access | Times Cited: 10
Scientific Advances in Understanding the Pathogenesis, Diagnosis, and Prevention of Urinary Tract Infection in the Past 10 Years
Daniel R. Engel, Florian Wagenlehner, Olga Shevchuk
Infectious Disease Clinics of North America (2024) Vol. 38, Iss. 2, pp. 229-240
Closed Access | Times Cited: 2
Opportunities and challenges in phage therapy for cardiometabolic diseases
Koen Wortelboer, Hilde Herrema
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 687-696
Closed Access | Times Cited: 2
Making the leap from technique to treatment — genetic engineering is paving the way for more efficient phage therapy
Jessica M. Lewis, Joshua Williams, Antonia P. Sagona
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1373-1384
Open Access | Times Cited: 2
The rise, fall, and resurgence of phage therapy for urinary tract infection
Jacob J. Zulk, Kathryn A. Patras, Anthony W. Maresso
EcoSal Plus (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 1
CRISPR-Cas9 enables efficient genome engineering of the strictly lytic, broad host-range staphylococcal bacteriophage K
Jonas Fernbach, Jasmin Baggenstos, Jeannine Riedo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Bacteriophage Therapy for Urinary Tract Infections
Matthew Dunne, Т С Перепанова, Truls E. Bjerklund Johansen
Springer eBooks (2024), pp. 189-205
Closed Access | Times Cited: 1
Innovations in Phage Therapy for Urinary Tract Infection
Lorenz Leitner, Thomas M. Kessler, Shawna McCallin
European Urology Focus (2024) Vol. 10, Iss. 5, pp. 722-725
Open Access | Times Cited: 1
Designing a simple and efficient phage biocontainment system using the amber suppressor initiator tRNA
Pamela R. Tsoumbris, Russel M. Vincent, Paul R. Jaschke
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Current status of clinical trials for phage therapy
Chidiebere Francis Uchechukwu, Adedayo Shonekan
Journal of Medical Microbiology (2024) Vol. 73, Iss. 9
Closed Access | Times Cited: 1
Wide‐Spectrum Nano‐Antibiotics Based on TPA‐Py@AuNCs⊂BSA for Multimodal Synergistic Therapy of Drug‐Resistant Bacteria and Wound Infections
Fengrui Xu, Ge Zhang, Kai Zhang, et al.
Aggregate (2024)
Open Access | Times Cited: 1
A bacterial genome assembly and annotation laboratory using a virtual machine
Ellina Trofimova, Shahla Asgharzadeh Kangachar, Karen D. Weynberg, et al.
Biochemistry and Molecular Biology Education (2023) Vol. 51, Iss. 3, pp. 276-285
Open Access | Times Cited: 2
Applications of designer phage encoding recombinant gene payloads
Daniel Schmitt, Sara D. Siegel, Kurt Selle
Trends in biotechnology (2023) Vol. 42, Iss. 3, pp. 326-338
Open Access | Times Cited: 2
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea
Monika Adamczyk-Popławska, Piotr Golec, Andrzej Piekarowicz, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 769-784
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top